PIK3CA and skin squamous cell carcinoma: A similar indication can also be found in another study regarding CSCC contributed by the same authors [95], who, using the ProfiLER trial platform, analyzed the PIK3CA mutation in CSCC, revealing that the PIK3CA mutation was most common among all mutated genes in patients with CSCC who initially underwent radiotherapy.